If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,432.00
Bid: 1,438.00
Ask: 1,440.00
Change: 5.00 (0.35%)
Spread: 2.00 (0.139%)
Open: 1,425.00
High: 1,443.00
Low: 1,423.00
Prev. Close: 1,427.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

29 Feb 2024 07:00

RNS Number : 8677E
Indivior PLC
29 February 2024
 

INDIVIOR PLC

TRANSACTIONS IN OWN SHARES

February 29, 2024

INDIVIOR PLC ("Indivior") announces that on February 28, 2024, it purchased for cancellation the following number of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc.

Ordinary Shares

Date of purchases:

February 28, 2024

Number of ordinary shares purchased:

5,733

Highest Price per share:

1,706.00

Lowest Price per share:

1,702.00

Volume Weighted Average Price per share:

1,704.54

Indivior intends to cancel all of the purchased shares.

All repurchases by Indivior are "On Exchange" transactions (as such term is defined in the rules of the London Stock Exchange) and "on market" for the purposes of the Companies Act 2006.

Following the above transaction and cancellation of the purchased shares, Indivior has 136,490,175 ordinary shares with voting rights in issue. There are no ordinary shares held in treasury.

The above figure (136,490,175) may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Indivior under the FCA's Disclosure Guidance and Transparency Rules.

Aggregated information

Trading Venue

Aggregated volume (shares)

Volume weighted average price (p)

XLON

5,733

1,704.54

Contact:

Jason Thompson

Vice President, Investor Relations

1-804-402-7123

Transaction details

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014, as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, a full breakdown of the individual purchases of ordinary shares made by Morgan Stanley & Co. International Plc on behalf of Indivior as part of the Share Repurchase Program is detailed below.

 

Time

Price (p)

Quantity

Venue

Reference

13:00:39

1,706.00

464

XLON

E0Htal0fngpz

13:00:39

1,706.00

29

XLON

E0Htal0fngq1

13:00:39

1,706.00

494

XLON

E0Htal0fngq3

13:36:58

1,706.00

524

XLON

E0Htal0foAUm

13:36:58

1,706.00

97

XLON

E0Htal0foAUr

13:36:58

1,706.00

612

XLON

E0Htal0foAUt

13:36:59

1,705.00

632

XLON

E0Htal0foAVi

13:36:59

1,705.00

514

XLON

E0Htal0foAVk

13:40:57

1,703.00

240

XLON

E0Htal0foE5V

13:40:57

1,703.00

548

XLON

E0Htal0foE5X

13:51:13

1,705.00

244

XLON

E0Htal0foNQT

13:52:07

1,705.00

250

XLON

E0Htal0foOSo

13:52:07

1,702.00

200

XLON

E0Htal0foOTG

13:52:07

1,702.00

146

XLON

E0Htal0foOTI

13:52:07

1,702.00

204

XLON

E0Htal0foOTK

13:52:07

1,702.00

6

XLON

E0Htal0foOTN

13:52:07

1,702.00

529

XLON

E0Htal0foOTR

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGZGZZGRNGDZZ
Date   Source Headline
1st Jun 20239:11 amRNSTotal Voting Rights
26th May 20234:20 pmRNSHolding(s) in Company
25th May 20232:30 pmRNSIndivior to Participate in Upcoming Conferences
24th May 20233:05 pmRNSHolding(s) in Company
23rd May 20236:05 pmRNSIndivior Files Form 20-F for US Listing
23rd May 20232:42 pmRNSHolding(s) in Company
23rd May 20238:30 amRNSHolding(s) in Company
23rd May 20237:00 amRNSUS FDA Approves OPVEE
12th May 20232:56 pmRNSHolding(s) in Company
10th May 20233:30 pmRNSDirector/PDMR Shareholding
10th May 202312:00 pmRNSBlock listing Interim Review
10th May 20238:51 amRNSHolding(s) in Company
4th May 20232:48 pmRNSResult of AGM
27th Apr 202312:00 pmRNS1st Quarter Results
25th Apr 20232:30 pmRNSIndivior to Participate in Conference
25th Apr 20239:26 amRNSHolding(s) in Company
20th Apr 20238:43 amRNSHolding(s) in Company
18th Apr 20238:09 amRNSHolding(s) in Company
17th Apr 20234:25 pmRNSHolding(s) in Company
11th Apr 20232:00 pmRNSNotice of Q1 Results
6th Apr 202312:24 pmRNSHolding(s) in Company
3rd Apr 20239:35 amRNSTotal Voting Rights
30th Mar 20232:37 pmRNSHolding(s) in Company
28th Mar 20233:21 pmRNSHolding(s) in Company
27th Mar 202311:42 amRNSAnnual Financial Report
24th Mar 20232:30 pmRNSDirector/PDMR Shareholding
23rd Mar 202310:02 amRNSBlock Listing of Shares
22nd Mar 20233:00 pmRNSDirector/PDMR Shareholding
16th Mar 20232:30 pmRNSDirector/PDMR Shareholding
15th Mar 20232:30 pmRNSDirector/PDMR Shareholding
13th Mar 20234:04 pmRNSDirector/PDMR Shareholding
13th Mar 20232:36 pmRNSHolding(s) in Company
8th Mar 20239:42 amRNSDirector/PDMR Shareholding
6th Mar 20234:00 pmRNSDirector/PDMR Shareholding
6th Mar 202310:21 amRNSHolding(s) in Company
2nd Mar 20231:56 pmRNSIndivior Completes Opiant Transaction
2nd Mar 20238:43 amRNSCompletion of Share Repurchase Program
1st Mar 20234:35 pmRNSDirector/PDMR Shareholding
1st Mar 202310:09 amRNSTotal Voting Rights
1st Mar 20237:00 amRNSTransaction in Own Shares
28th Feb 20237:00 amRNSTransaction in Own Shares
27th Feb 20234:18 pmRNSHolding(s) in Company
27th Feb 20237:00 amRNSTransaction in Own Shares
24th Feb 20237:00 amRNSTransaction in Own Shares
23rd Feb 20237:00 amRNSTransaction in Own Shares
22nd Feb 20234:52 pmRNSHolding(s) in Company
22nd Feb 20237:00 amRNSTransaction in Own Shares
21st Feb 202312:15 pmRNSIndivior to Participate in Conference
21st Feb 20239:09 amRNSHolding(s) in Company
21st Feb 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.